• Healthcare

    In the Healthcare Services segment, attractive investment opportunities are driven by capacity expansion, consolidation amongst service providers, and value creation through service improvement in what continues to be a fragmented and inefficient market.

     

    In the Pharma and Medtech segments, we seek to identify companies that stand to benefit from trends towards enhanced consumer choice, improved information available to patients and prevention over treatment.

  • Meet the team

    Frédéric Stévenin

    Stefano Drago

    Augustin Grandcolas

    Andreas Kumeth

    Arnaud van Tichelen

    Sébastien Veil

  • Veonet

    Veonet is a leading pan-European ophthalmology clinics platform.

    Healthcare
  • Amplitude Surgical

    Leading French player on the global surgical technology market for lower-limb orthopaedics.

    Healthcare
  • Zahneins

    Zahneins is a leading German dental company.

    Healthcare
    • Investment date December 2019
    • Fund PAI Europe VII
    • Headquarters Germany
    • www.zahneins.com
  • ELITechGroup

    ELITechGroup is a global leader in specific niches of the in-vitro diagnostics market.

    Healthcare
    • Investment date July 2017
    • Fund PAI Europe VI
    • Value at acquisition €355m
    • Headquarters France
    • www.elitechgroup.com
  • Atos Medical

    Atos Medical is the world leading provider of laryngectomy products.

    Healthcare
    • Exit date January 2022
    • Investment date July 2016
    • Fund PAI Europe VI
    • Value at acquisition SEK 7.7bn
    • Value at exit SEK 22.6bn
    • Headquarters Sweden
    • www.atosmedical.com
  • Ethypharm

    Ethypharm is a specialty pharmaceutical company active in the central nervous system and critical care areas with leading positions in pain and addiction treatments.

    Healthcare
    • Investment date July 2016
    • Fund PAI Europe VI
    • Value at acquisition €725m
    • Headquarters France
    • www.ethypharm.com
  • DomusVi

    DomusVi is a leading player in the European nursing home sector.

    Healthcare
    • Exit date July 2017
    • Investment date September 2014
    • Fund PAI Europe VI
    • Value at acquisition €639m
    • Value at exit €2.4bn
    • Headquarters France
    • www.domusvi.com
  • Cerba Healthcare

    Cerba is a leading international operator of clinical pathology laboratories.

    Healthcare
    • Exit date April 2017
    • Investment date July 2010
    • Fund PAI Europe V
    • Value at acquisition €551m
    • Value at exit €1.8bn
    • Headquarters France
    • www.cerbahealthcare.com
  • Ceva

    Animal health products.

    Healthcare
    • Exit date September 2003
    • Investment date October 1999
    • Fund PAI LBO Fund
    • Value at acquisition €71m
    • Value at exit €202m
    • Headquarters France
    • www.ceva.com/en/
  • Ipsen

    Pharmaceutical laboratory.

    Healthcare
    • Exit date June 2006
    • Investment date December 1998
    • Fund PAI LBO Fund
    • Value at acquisition €1.3bn
    • Value at exit €2.1bn
    • Headquarters France
    • www.ipsen.com
Back to top